CAS 869464-83-5

6-Phenyl-1-(4-pyridinylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

Description:

6-Phenyl-1-(4-pyridinylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid is a heterocyclic compound characterized by its complex structure, which includes a pyrazolo[3,4-b]pyridine core fused with a phenyl group and a pyridinylmethyl substituent. This compound features a carboxylic acid functional group, contributing to its potential acidity and reactivity. The presence of both the phenyl and pyridine moieties suggests that it may exhibit interesting electronic properties, potentially influencing its interactions in biological systems or as a ligand in coordination chemistry. The compound's structure may allow for various hydrogen bonding and π-π stacking interactions, which can be significant in drug design and molecular recognition. Additionally, the presence of multiple aromatic rings may enhance its stability and lipophilicity, making it a candidate for further studies in medicinal chemistry. Overall, this compound's unique structural features may provide avenues for research in pharmacology and material science.

Formula: C₁₉H₁₄N₄O₂

InChI: InChI=1S/C19H14N4O2/c24-19(25)15-10-17(14-4-2-1-3-5-14)22-18-16(15)11-21-23(18)12-13-6-8-20-9-7-13/h1-11H,12H2,(H,24,25)

InChI key: InChIKey=KCTGBSZXRNRGOD-UHFFFAOYSA-N

SMILES: C(N1C=2C(=C(C(O)=O)C=C(N2)C3=CC=CC=C3)C=N1)C=4C=CN=CC4

Synonyms:

• 1H-Pyrazolo[3,4-b]pyridine-4-carboxylic acid, 6-phenyl-1-(4-pyridinylmethyl)-
• 6-Phenyl-1-(4-pyridinylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

6-Phenyl-1-[(pyridin-4-yl)methyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

CAS: 869464-83-5

6-Phenyl-1-[(pyridin-4-yl)methyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid (6PPC) is a proton pump inhibitor that inhibits gastric acid secretion by blocking H+/K+ ATPase. It has been shown to be effective in treating autoimmune diseases and hypertension. 6PPC is used to treat a number of diseases, including inflammatory bowel disease, ulcerative colitis, and Crohn's disease. This drug also inhibits the activity of cannabinoid receptors and has been shown to inhibit the growth of cancer cells in cell culture and animal models.

Formula: C₁₉H₁₄N₄O₂

Purity: Min. 95%

Molecular weight: 330.3 g/mol

Ref: 3D-UJB46483